scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0010-7824(79)80038-4 |
P698 | PubMed publication ID | 535366 |
P2093 | author name string | A. Balogh | |
M. Lindberg | |||
E. Diczfalusy | |||
B. M. Landgren | |||
M. W. Shin | |||
P2860 | cites work | Disappearance Rates of Endogenous Luteinizing Hormone and Chorionic Gonadotropin in Man | Q72154563 |
Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle | Q93700925 | ||
The effect of chlormadinone acetate on progesterone secretion and metabolism | Q93713950 | ||
Studies on the metabolic clearance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man | Q35194276 | ||
Measurement of the production rate of human luteinizing hormone using the urinary excretion technique | Q39099768 | ||
Influence of the purity of the iodinated tracer on the specificity of the radioimmunoassay of human luteinizing hormone | Q40951323 | ||
Biologically active luteinizing hormone (LH) in plasma. IV. Comparison with immunologically active LH in plasma of men | Q41528358 | ||
Studies on the Mechanism of Action of Continuous Microdose Quingestanol Acetate | Q42448326 | ||
Effects of 0.5 mg. of lynestrenol daily on hypothalamic-pituitary-ovarian function | Q43967649 | ||
Biological and immunological characterization of human luteinizing hormone: IV. Biological and immunological profile of two international reference preparations after electrofocusing | Q53446049 | ||
Biological and immunological characterization of human luteinizing hormone: II. A comparison of the immunological and biological activities of pituitary extracts after electrofocusing using different standard preparations | Q67042237 | ||
An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations | Q68702760 | ||
Pituitary and ovarian function in women on continuous low dose progestogens; effect of chlormadinone acetate and norethisterone | Q70124763 | ||
Effects Of Microdose Norgestrel On Endogenous Gonadotropic And Steroid Hormones, Cervical Mucus Properties, Vaginal Cytology, And Endometrium , | Q70562591 | ||
Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens | Q71566935 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biology | Q420 |
oral contraceptive | Q3344800 | ||
clinical research | Q5133849 | ||
physiology | Q521 | ||
pituitary gonadotropins | Q76787944 | ||
glyco-Lutropin [extracellular region] | Q50265477 | ||
follicle stimulating hormone | Q66590069 | ||
P304 | page(s) | 585-605 | |
P577 | publication date | 1979-12-01 | |
P1433 | published in | Contraception | Q2995704 |
P1476 | title | Hormonal effects of the 300 microgram norethisterone (NET) minipill. 2. Daily gonadotrophin levels in 43 subjects during a pretreatment cycle and during the second month of NET administration | |
P478 | volume | 20 |
Q54375873 | Effect of brivaracetam (400 mg/day) on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive in healthy women. |
Q67812479 | Effects of intranasal administration of norethisterone on folliculogenesis, cervical mucus, vaginal cytology, endometrial morphology and reproductive-endocrine profile in women |
Q37590032 | Mechanism of action of gestagens |
Q34082948 | Ovarian function during and after treatment with the new progestagen Org 30659. |
Q72819893 | Ovarian function following a single administration of depomedroxyprogesterone acetate (DMPA) at different doses |
Q70451295 | Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate |
Q71338870 | Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraception |
Search more.